Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Giant Cell Tumors

• A Study to Evaluate the Efficacy and Safety of Narlumosbart (JMT103) in Patients With Giant Cell Tumor of Bone
• Study of Pimicotinib (ABSK021) for Tenosynovial Giant Cell Tumor
• Study of Emactuzumab for Tenosynovial Giant Cell Tumor (TGCT)
• Study of Vimseltinib for Tenosynovial Giant Cell Tumor
• A Study of Pexidartinib in Tenosynovial Giant Cell Tumor in Japan
• Study of XGEVA® (Denosumab) in Chinese Adults and Skeletally Mature Adolescents With Giant Cell Tumor of the Bone
• Study to Evaluate Discontinuation and Re-Treatment in Participants With Tenosynovial Giant Cell Tumor (TGCT) Previously Treated With Pexidartinib
• A Study of the Efficacy and Safety of Pexidartinib in Adult Subjects With TGCT
• Reduced Dose-density of Denosumab for Unresectable GCTB
• LN-145 or LN-145-S1 in Treating Patients With Relapsed or Refractory Ovarian Cancer, Anaplastic Thyroid Cancer, Osteosarcoma, or Other Bone and Soft Tissue Sarcomas
• Long-term Safety Follow-up of Subjects With Giant Cell Tumor of Bone Treated With Denosumab in Study 20062004
• Local Bisphosphonate Effect on Recurrence Rate in Extremity Giant Cell Tumor of Bone
• Characteristics and Mechanism of Denosumab-treated Giant Cell Tumor of Bone
• Study of DCC-3014 in Patients With Advanced Tumors and Tenosynovial Giant Cell Tumor
• A Study of PLX73086 in Advanced Solid Tumors and Locally Advanced or Refractory Tenosynovial Giant Cell Tumor
• Study of FPA008 in Patients With Pigmented Villonodular Synovitis / Diffuse Type Tenosynovial Giant Cell Tumor
• Phase 3 Study of Pexidartinib for Pigmented Villonodular Synovitis (PVNS) or Giant Cell Tumor of the Tendon Sheath (GCT-TS)
• Phase 1 Study of PLX7486 as Single Agent in Patients With Advanced Solid Tumors
• MCS110 in Patients With Pigmented Villonodular Synovitis (PVNS)
• Study of the Effect of Zoledronate on Local Recurrence After Surgical Treatment of Giant Cell Tumors of Bone Zométa
• Study of Nilotinib Efficacy in Pigmented Villo-Nodular Synovitis/ Tenosynovial Giant Cell Tumour (PVNS/TGCT)
• Nilotinib in Patients With Relapsed or Metastatic Pigmented Villonodular Synovitis/Tenosynovial Giant Cell Tumor/Diffuse-Type Giant Cell Tumor
• Adjuvant Zoledronic Acid in High Risk Giant Cell Tumour of Bone (GCT)
• Study of Denosumab in Subjects With Giant Cell Tumor of Bone
• Trial of Dasatinib in Advanced Sarcomas